SERCA2a-phospholamban interaction monitored by an interposed circularly permutated green fluorescent protein.


Journal

American journal of physiology. Heart and circulatory physiology
ISSN: 1522-1539
Titre abrégé: Am J Physiol Heart Circ Physiol
Pays: United States
ID NLM: 100901228

Informations de publication

Date de publication:
01 06 2021
Historique:
pubmed: 17 4 2021
medline: 24 7 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

The interaction of phospholamban (PLB) and the sarcoplasmic reticulum Ca

Identifiants

pubmed: 33861144
doi: 10.1152/ajpheart.00858.2020
pmc: PMC8289358
doi:

Substances chimiques

Calcium-Binding Proteins 0
DNA, Complementary 0
Recombinant Fusion Proteins 0
Recombinant Proteins 0
phospholamban 0
Green Fluorescent Proteins 147336-22-9
Cyclic AMP-Dependent Protein Kinases EC 2.7.11.11
Sarcoplasmic Reticulum Calcium-Transporting ATPases EC 3.6.3.8

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

H2188-H2200

Subventions

Organisme : NHLBI NIH HHS
ID : R00 HL124041
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL122744
Pays : United States
Organisme : HHS | National Institutes of Health (NIH)
ID : R01 HL-122744

Références

J Mol Cell Cardiol. 2019 Feb;127:165-173
pubmed: 30550750
J Am Coll Cardiol. 2008 Mar 18;51(11):1112-9
pubmed: 18342232
Biophys J. 1995 Jan;68(1):208-15
pubmed: 7711243
J Clin Invest. 2003 Mar;111(6):869-76
pubmed: 12639993
Lancet. 2016 Mar 19;387(10024):1178-86
pubmed: 26803443
Circulation. 2000 May 9;101(18):2193-9
pubmed: 10801761
Circulation. 1999 Aug 31;100(9):974-80
pubmed: 10468529
Circ Res. 2007 Nov 26;101(11):1123-9
pubmed: 17975108
Cell Calcium. 2011 Jul;50(1):1-8
pubmed: 21529938
Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):365-70
pubmed: 18165313
Cell. 1999 Oct 29;99(3):313-22
pubmed: 10555147
Biochemistry. 2004 Jul 13;43(27):8754-65
pubmed: 15236584
Cardiovasc Drugs Ther. 2001 Sep;15(5):387-96
pubmed: 11855657
J Biol Chem. 2000 May 19;275(20):15034-8
pubmed: 10809745
Biochemistry. 2002 Jan 22;41(3):741-51
pubmed: 11790095
Virology. 1973 Apr;52(2):456-67
pubmed: 4705382
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10061-6
pubmed: 11526231
Am J Physiol. 1991 Oct;261(4 Pt 2):H1344-9
pubmed: 1681743
Cardiovasc Res. 2002 Feb 1;53(2):382-91
pubmed: 11827689
J Am Coll Cardiol. 2011 Jul 5;58(2):147-54
pubmed: 21718911
Physiol Rev. 1994 Apr;74(2):365-507
pubmed: 8171118
J Biol Chem. 1991 Jun 15;266(17):11270-5
pubmed: 1710223
Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4753-8
pubmed: 16537386
J Mol Cell Cardiol. 1999 Mar;31(3):479-91
pubmed: 10198180
Circulation. 1995 Dec 1;92(11):3220-8
pubmed: 7586307
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11241-6
pubmed: 10500161
Nat Rev Mol Cell Biol. 2003 Jul;4(7):566-77
pubmed: 12838339
J Biol Chem. 2007 Jul 20;282(29):20968-76
pubmed: 17548345
Nature. 1998 Apr 23;392(6678):835-9
pubmed: 9572145
J Mol Cell Cardiol. 1988 Mar;20 Suppl 2:3-13
pubmed: 2842510
Nat Biotechnol. 2001 Feb;19(2):137-41
pubmed: 11175727
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17338-43
pubmed: 24101520
Circ Res. 2012 Jun 8;110(12):1646-60
pubmed: 22679139
Sci Rep. 2018 Aug 22;8(1):12560
pubmed: 30135432
Am J Physiol Heart Circ Physiol. 2013 Sep 1;305(5):H706-15
pubmed: 23812383
Biophys J. 1995 Mar;68(3):936-45
pubmed: 7756557
Nature. 1989 Nov 2;342(6245):90-2
pubmed: 2530454
Am J Physiol Heart Circ Physiol. 2000 Jan;278(1):H249-55
pubmed: 10644605
Circ Res. 1994 Sep;75(3):401-9
pubmed: 8062415
J Clin Invest. 1997 Jul 15;100(2):380-9
pubmed: 9218515
Ann N Y Acad Sci. 1998 Sep 16;853:31-42
pubmed: 10603934
J Physiol. 2003 Nov 1;552(Pt 3):845-57
pubmed: 12923217
Circulation. 1995 Aug 15;92(4):778-84
pubmed: 7641356
Biochemistry. 1998 Feb 24;37(8):2410-21
pubmed: 9485389
Ann N Y Acad Sci. 1998 Sep 16;853:186-94
pubmed: 10603946
Adv Exp Med Biol. 1989;255:79-89
pubmed: 2559607
J Biol Chem. 1993 Feb 5;268(4):2809-15
pubmed: 8428955
FASEB J. 2004 Aug;18(11):1312-4
pubmed: 15180962

Auteurs

Maren E Arnold (ME)

Department of Medicine and Molecular Physiology and Biophysics, University of Vermont Larner College of Medicine, Burlington, Vermont.
Institute of Experimental and Clinical Pharmacology und Toxicology, Faculty of Medicine, Albert-Ludwigs-University Freiburg, Freiburg, Germany.

Wolfgang R Dostmann (WR)

Department of Pharmacology, University of Vermont Larner College of Medicine, Burlington, Vermont.

Jody Martin (J)

Department of Pharmacology, School of Medicine, Cardiovascular Research Institute, University of California, Davis, California.

Michael J Previs (MJ)

Department of Medicine and Molecular Physiology and Biophysics, University of Vermont Larner College of Medicine, Burlington, Vermont.

Bradley Palmer (B)

Department of Medicine and Molecular Physiology and Biophysics, University of Vermont Larner College of Medicine, Burlington, Vermont.

Martin LeWinter (M)

Department of Medicine and Molecular Physiology and Biophysics, University of Vermont Larner College of Medicine, Burlington, Vermont.

Markus Meyer (M)

Department of Medicine, Lillehei Heart Institute, University of Minnesota College of Medicine, Minneapolis, Minnesota.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH